This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Syringomyelia and syringobulbiaSyringomyelia and Syringobulbia

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: G95.0 | Special Copayment Reduction: V172 (5 years)
B. SynonymsSyringomyelia, syringobulbia, intramedullary cyst, hydromyelia
C. Adult onsetHigh likelihood of first presenting in adulthood — Chiari I–associated form commonly begins in the 20s–40s; traumatic and tumor-related causes are also common in adults
1. HistoryEstienne's first autopsy description (1546), Ollivier's establishment of the terminology, discovery of the association between Chiari malformation and syringomyelia, diagnostic revolution of the MRI era
2. CausesChiari I malformation (most common), trauma, spinal cord tumor, arachnoiditis, scoliosis, idiopathic
3. GeneticsMostly nonhereditary; familial cases reported in association with Chiari I malformation; COL1A1/COL1A2-related connective tissue abnormality possible
4. EpidemiologyPrevalence about 8 per 100,000; Chiari I association most common; female = male; peak symptom onset in the 20s–40s
5. PathophysiologyImpaired cerebrospinal fluid (CSF) flow → abnormal pressure transmission within the spinal cord → fluid accumulation in the extracellular space → syrinx formation (Oldfield theory, Williams theory)
6. SymptomsCape-distribution dissociated sensory loss (loss of pain and temperature, preserved touch and proprioception), upper limb weakness and atrophy, headache (provoked by cough/Valsalva)
7. SignsDissociated sensory loss, flaccid paralysis of the upper limbs/spastic paralysis of the lower limbs, autonomic abnormalities (sweating, bladder), cranial nerve palsies in syringobulbia
8. ScreeningMRI (brain and spinal cord) in patients with suboccipital headache + abnormal sensation; spinal cord MRI screening in patients with Chiari malformation
9. DiagnosisMRI spinal cord sagittal plane (size and extent of syrinx, accompanying Chiari); phase-contrast CSF flow MRI; CSF analysis (to exclude tumor)
10. TreatmentTreat the cause first: Chiari → posterior fossa decompression (craniectomy + duraplasty); tumor → resection; syrinx-peritoneal shunt
11. PrognosisSyrinx reduction and symptom improvement possible after correcting the cause; the goal is stabilization of neurological function after surgery; halting progression is more realistic than complete recovery
12. PreventionConsider preemptive surgery after diagnosis of Chiari I before symptoms progress; MRI follow-up after traumatic spinal cord injury; early detection of spinal cord tumor
13. ReferencesOldfield EH et al. (1994) and 9 other key papers

1. History

The history of syringomyelia goes back to 16th-century anatomy. The first record in the literature is the description of a cavity inside the spinal cord in an autopsy report by the French anatomist Charles Estienne in 1546. Later, in the 18th–19th centuries, several anatomists reported similar findings. In 1827 the French physician Charles-Prosper Ollivier d'Angers coined the term "syringomyelia," a compound of the Greek "syrinx" (reed, tube) and "myelos" (spinal cord). Ollivier suggested that this cavity might be connected to the central canal of the spinal cord.

In the late 19th century, Hans Chiari (1891, 1896) classified several congenital malformations associated with downward displacement of the cerebellar tonsils below the foramen magnum (tonsillar ectopia) and described Chiari malformations types I–IV. The association between Chiari I malformation and syringomyelia was recognized from that time, but understanding of the pathophysiological mechanism came much later. In 1965 Gardner and Angel proposed the CSF flow theory, and in 1994 Oldfield et al., using phase-contrast MRI, visualized in real time the systolic-diastolic CSF flow abnormality in Chiari I malformation and reported that posterior fossa decompression restores CSF flow and the syrinx shrinks. The clinical introduction of MRI (magnetic resonance imaging) in the 1980s brought a revolutionary change to the diagnosis of syringomyelia. Syrinxes that previously could be confirmed only by myelography or autopsy could now be accurately visualized noninvasively with MRI, making diagnosis at the asymptomatic stage and follow-up before and after treatment possible.

2. Causes

The causes of syringomyelia are diverse, and in common, impaired CSF circulation or abnormal pressure transmission within the spinal cord forms the basis of syrinx formation.

Chiari I malformation: The most common cause, in which the cerebellar tonsils descend 5 mm or more below the foramen magnum and mechanically obstruct CSF flow. Chiari I malformation is the cause in about 50–65% of patients with syringomyelia. Syringobulbia is mainly a form accompanying Chiari I in which the syrinx extends into the brainstem (medulla).

Post-traumatic syringomyelia: It can occur years to decades after spinal cord injury. Arachnoid adhesions and scar formation at the site of spinal cord injury locally obstruct CSF flow, forming a syrinx. It is estimated to occur in about 2–3% of patients with spinal cord injury.

Spinal cord tumor: Intramedullary tumors (intramedullary ependymoma, hemangioblastoma, astrocytoma) form a syrinx directly or cause a secondary syrinx around the tumor. In this case the tumor and the syrinx must be distinguished on contrast-enhanced MRI.

Arachnoiditis and subarachnoid hemorrhage: After bacterial meningitis, tuberculous meningitis or subarachnoid hemorrhage (SAH), arachnoid adhesions obstruct CSF flow and form a syrinx. Subarachnoid space scanning (including sequelae of past procedures such as residual pantopaque oil in the CSF) can also be a cause.

Spinal deformity: Severe scoliosis and spinal fusion abnormalities (tethered cord syndrome) are associated with syrinx formation.

Idiopathic: Cases in which none of the above causes can be identified, accounting for about 10–15% of the total.

3. Genetics

Syringomyelia itself is not a genetic disease and is mostly a secondary lesion due to acquired or congenital structural abnormalities. However, familial clustering has been reported in Chiari I malformation, the underlying cause, so genetic vulnerability may be involved in a minority of cases.

Heritability of Chiari I malformation: Cases have been reported in which multiple members of a family show Chiari I malformation, and family studies report that radiological Chiari I malformation is found in about 12–25% of first-degree relatives. Pedigrees suggesting an autosomal dominant mode of inheritance exist, but no single causative gene has been established. Research is under way on genes related to development of the suboccipital skull and cervical spine (BBOX1, RELN, etc.).

Association with connective tissue abnormalities: In hereditary connective tissue diseases such as Marfan syndrome (FBN1), Ehlers-Danlos syndrome (COL5A1, COL3A1, etc.) and osteogenesis imperfecta (COL1A1/COL1A2), craniocervical junction abnormalities and Chiari malformation, and further syringomyelia, may accompany them. In this case, diagnosis of the hereditary connective tissue disease takes priority.

Post-traumatic syringomyelia: In traumatic causes, the severity of the trauma, the level of spinal cord injury and the subsequent rehabilitation course are more important determinants of syrinx formation than genetic predisposition.

4. General epidemiology

The prevalence of syringomyelia is estimated at about 8–10 per 100,000 in the general population. Before the MRI era, diagnosis before symptom onset was difficult, but since MRI became widespread, the frequency of incidentally discovered asymptomatic syrinx (incidental syrinx) has also come to be recognized. In population-based MRI studies, the prevalence of small asymptomatic spinal cord syrinx has been reported at the 0.9–2.3% level.

Sex and age: Overall there is no large difference in prevalence between men and women, but some studies report a slightly higher number of women. The age at symptom onset differs by cause. Chiari I–associated syringomyelia most commonly becomes symptomatic in the 20s–40s, and onset in childhood also occurs. Post-traumatic syringomyelia occurs years or more after spinal cord injury and therefore varies with the age at injury. Spinal cord tumor–associated syringomyelia coincides with the age of tumor occurrence.

Distribution by cause: Chiari I association is most common (50–65%), followed in order by post-traumatic (about 15–20%), idiopathic (10–15%), tumor-associated (5–10%) and arachnoiditis-associated (5%). It is reported that syringobulbia accompanies about 20–30% of patients with syringomyelia, and isolated syringobulbia is rare.

5. Pathophysiology

The pathophysiology of syringomyelia has been debated for decades, and several theories are now applied in an integrated manner.

Williams theory (1969/1980): When intrathoracic pressure rises, as in coughing, Valsalva maneuvers and sneezing, reflux of blood flow in the spinal epidural venous plexus transiently raises pressure on the ventral side of the spinal cord, while intracranial CSF pressure rises later. This theory holds that this momentary spinal–cranial pressure difference ("craniospinal pressure dissociation") forcibly sucks CSF into the central canal of the spinal cord and causes syrinx enlargement.

Oldfield theory (1994): In phase-contrast MRI studies, a phenomenon was observed in which, during systole in patients with Chiari I malformation, the cerebellar tonsils move downward like a piston and compress CSF around the spinal cord, thereby injecting CSF into the spinal cord. CSF absorption through the outside and inside of the pia mater of the spinal cord (perivascular/interstitial spaces) and its accumulation in the central canal or extracellular space is the key mechanism of syrinx formation.

Integrated model of hydrodynamic and CSF flow disturbance: Whatever the cause, when CSF flow is blocked at the level of the foramen magnum or at a specific segment within the spinal cord, the systolic CSF pressure wave cannot be dissipated normally in the extramedullary space and is instead transmitted into the spinal cord, and extracellular fluid accumulation and syrinx formation progress. The effectiveness of posterior fossa decompression for syrinx reduction in Chiari I malformation strongly supports this theory.

Pathophysiology of syringobulbia: When syringomyelia extends upward to reach the brainstem (medulla), syringobulbia forms. The syrinx in the medulla appears as a slit or line in one or both sides of the medulla and involves the centers for the tongue, facial sensation, swallowing, phonation and respiration. Syringobulbia is mostly continuous with syringomyelia but rarely occurs independently.

6. Symptoms

The symptoms of syringomyelia vary according to the location of the syrinx (cervical, thoracic, lumbar), its size, rate of expansion and whether the medulla is involved.

Cape-distribution dissociated sensory loss: This is the most characteristic symptom. When a syrinx in the center of the spinal cord involves the anterior white commissure, the fibers responsible for pain and temperature sensation are blocked first, while touch, vibration and proprioception, which travel through the posterior columns, are relatively preserved. As a result, loss of pain and temperature sensation is distributed in a "cape" shape across the nape, shoulders, arms and upper chest. Patients often cannot feel pain even when injured by hot water or sharp objects and frequently suffer repeated burns and lacerations.

Upper limb weakness and atrophy: When the syrinx involves the anterior horn, lower motor neuron weakness (flaccid paralysis, decreased reflexes, muscle atrophy, fibrillation potentials) occurs. Atrophy of the intrinsic hand muscles is mainly the initial finding and may appear together with Wartenberg's sign (abducted position of the little finger).

Headache: Suboccipital headache (occipital and neck pain) is common in the Chiari I–associated form. A diagnostically important feature is that the headache is markedly aggravated by coughing, sneezing, Valsalva maneuvers and bending the head down ("cough headache").

Spinal pain and non-radicular pain: Cervical and thoracic pain is common, and abnormal-sensation (neuropathic) pain occurring without nerve root compression also appears.

Autonomic abnormalities: Sweating abnormalities (increased or decreased sweating on one side of the body), bladder dysfunction (urge incontinence, impaired bladder voiding), erectile dysfunction in men and orthostatic hypotension may occur.

Specific symptoms of syringobulbia: Involvement of cranial nerve nuclei may produce loss of facial sensation (trigeminal nucleus), dysphagia and odynophagia (glossopharyngeal and vagal nuclei), hoarse voice (recurrent laryngeal nerve), tongue atrophy and fasciculations (hypoglossal nucleus), Horner syndrome (sympathetic pathway) and ataxia (involvement of cerebellar pathways). Involvement of the respiratory center (nuclei generating respiratory rhythm) carries a risk of sleep-disordered breathing and sudden death during sleep.

7. Signs

Physical examination findings reflect the anatomical location and extent of involvement of the syrinx.

Dissociated sensory loss: The typical pattern on neurological examination is coexistence of reduced or absent pinprick pain sensation and hot-cold discrimination (damage to the anterior commissure fibers) with preserved vibration and position sense (posterior columns). Depending on the location of the syrinx, this dissociated sensory loss corresponds to the cervical to thoracic dermatomes and appears first in the upper limbs rather than the lower limbs.

Flaccid paralysis of the upper limbs: Atrophy of the intrinsic hand muscles (thenar, hypothenar and interossei), reduced MRC grade, and decreased or absent deep tendon reflexes (upper limbs) are findings of anterior horn involvement.

Spastic paralysis of the lower limbs: When the syrinx involves the lateral corticospinal tract, upper motor neuron symptoms (spasticity, hyperreflexia, positive Babinski sign) appear in the lower limbs. In this case, lower limb gait disturbance and a spastic gait pattern are observed.

Cranial nerve signs (syringobulbia): Decreased facial sensation (onion-skin pattern when the ventral trigeminal nucleus is damaged), deviation of the uvula, impaired elevation of the soft palate, hoarse voice, tongue fasciculations and atrophy, regurgitation on swallowing, and nystagmus are observed. If Horner syndrome (miosis, ptosis, anhidrosis) is identified, it suggests involvement of the sympathetic pathway.

Arthropathy in syringomyelia (Charcot joint): Neuropathic arthropathy, in which joint destruction progresses owing to repeated trauma from loss of pain sensation, can occur in the shoulder, elbow and wrist (a relatively uncommon complication).

Scoliosis: In children and adolescents, syringomyelia can be a cause of scoliosis, and spinal cord MRI is recommended in pediatric patients with scoliosis of unknown cause.

8. Screening

MRI is the most sensitive and specific screening and diagnostic tool for syringomyelia.

Brain and spinal cord MRI: ① Patients with suboccipital headache (aggravated by cough): perform MRI of the craniocervical junction including the level of the foramen magnum and the entire spinal cord to evaluate Chiari malformation and syrinx simultaneously. ② Patients with dissociated sensory loss and upper limb atrophy: cervical to thoracic spinal cord MRI is essential. ③ Patients with confirmed Chiari I malformation: screen for syrinx formation with spinal cord MRI regardless of the presence of symptoms. ④ Neurological deterioration after spinal cord injury: perform follow-up spinal cord MRI, suspecting the development of post-traumatic syringomyelia.

Screening of scoliosis of unknown cause: In children and adolescents with scoliosis of unknown cause (especially when accompanied by neurological abnormalities or when the curve increases rapidly), screening for syringomyelia by spinal cord MRI is recommended.

Evaluation of spinal cord tumor: Contrast-enhanced MRI is used to evaluate for the presence of an intramedullary tumor and a tumor-associated syrinx. If the inner wall of the syrinx is smooth and shows a homogeneous signal, a reactive syrinx is likely, and nodular enhancement suggests a tumor or hemangioblastoma.

9. Diagnosis

The diagnosis of syringomyelia is based on MRI and incorporates additional tests to identify the cause.

Spinal cord MRI (sagittal and axial): On T1-weighted images a low-signal syrinx is seen in the center of the spinal cord, and on T2-weighted images a high-signal (fluid signal) syrinx. Describe the location of the syrinx (cervical, thoracic, cervicothoracic), its craniocaudal extent, transverse diameter (ratio to cord diameter) and the presence of septations. The position of the cerebellar tonsils below the foramen magnum is measured to determine the presence of Chiari I malformation (tonsillar descent of 5 mm or more).

Phase-contrast CSF flow MRI: Measures the systolic/diastolic flow velocity and direction of CSF synchronized to the heartbeat. In Chiari I malformation, compared with normal individuals, systolic CSF flow at the level of the foramen magnum is observed to be reduced, reversed or asymmetric. This test is used to determine surgical indications and to evaluate changes in CSF flow before and after surgery.

Contrast-enhanced MRI: Gadolinium contrast is given for differentiation from spinal cord tumors, hemangioblastoma and inflammatory lesions (multiple sclerosis, myelitis). An enhancing nodule within the syrinx strongly suggests hemangioblastoma or ependymoma.

Cerebrospinal fluid (CSF) analysis: Performed when tumor, arachnoiditis or infection is suspected. Elevated CSF protein, increased cells, cytology and tumor marker analysis are used to differentiate the cause.

Nerve conduction studies and electromyography: Confirm the extent of lower motor neuron involvement in the upper limbs and support differentiation from cervical myelopathy and peripheral nerve disease.

10. Treatment

The principle of treating syringomyelia is to correct the cause of syrinx formation rather than to remove the syrinx directly.

Chiari I malformation–associated syringomyelia: posterior fossa decompression: This is the standard treatment. CSF flow is restored by enlarging the foramen magnum with suboccipital craniectomy, resection of the posterior arch of C1 (including C2 if needed) and duraplasty. The syrinx shrinks and symptoms improve over several months after surgery. According to the literature, syrinx reduction in 70–80% of patients and stabilization or improvement of symptoms in 50–70% have been reported after surgery. Performing tonsillar coagulation at the same time may enhance the restoration of CSF flow.

Spinal cord tumor–associated syringomyelia: tumor resection: Surgical resection of the causative tumor (hemangioblastoma, ependymoma, astrocytoma) takes priority. After complete resection, the syrinx often shrinks spontaneously.

Arachnoiditis and post-traumatic syringomyelia: lysis of adhesions and shunting: Perispinal arachnoid adhesions are lysed, and if needed intrathecal steroid injection, syringosubarachnoid shunt or syringopleural shunt is performed. Shunting is used when the syrinx is large and progressive and the cause is difficult to correct directly.

Syrinx-subarachnoid or syrinx-peritoneal shunt: A thin tube is inserted into the syrinx to drain CSF into the subarachnoid space or the peritoneal cavity. It is a second-line option when there is no response to decompression or correction of the cause is impossible, and carries a risk of procedure-related complications such as obstruction and displacement.

Conservative management: For small asymptomatic syrinxes or when surgical indications are not met, periodic MRI follow-up and symptom monitoring are performed. For Valsalva-induced headache, intracranial pressure–lowering medication (acetazolamide) may partially help relieve symptoms. Gabapentin, pregabalin and tricyclic antidepressants are used for pain control.

Rehabilitation: Includes physical therapy to maintain upper and lower limb function, management of autonomic abnormalities (bladder training, clean intermittent self-catheterization) and swallowing rehabilitation.

11. Prognosis

The prognosis of syringomyelia varies according to cause, timing of diagnosis, syrinx size and surgical outcome.

In Chiari I malformation–associated syringomyelia, syrinx reduction after posterior fossa decompression begins 3–6 months after surgery, and partial or complete syrinx reduction is observed in 50–80% of patients. Symptom improvement often appears more slowly than the change in syrinx size, and in some patients existing neurological damage does not recover even though the syrinx shrinks. This is because neuronal necrosis that has progressed over a long period is irreversible. The postoperative goal is to halt the progression of symptoms and prevent new loss of neurological function, and functional stabilization rather than complete recovery of existing neurological deficits is the realistic goal.

Post-traumatic syringomyelia is diagnosed when function declines further below the neurological function predicted for the level of spinal cord injury ("ascending paraplegia"), and progression can be halted with appropriate treatment. The prognosis of tumor-associated syringomyelia is determined by the biological behavior of the tumor.

Syringomyelia left untreated may worsen progressively and advance to quadriplegia, respiratory failure and medullary symptoms. When syringobulbia is present, there is a risk of sudden respiratory arrest due to involvement of the respiratory center, so more aggressive surgical intervention is considered. The risks of surgical treatment (worsening nerve damage, CSF leak, infection) and its benefits must be carefully evaluated in the context of the individual patient.

12. Prevention

Primary prevention of syringomyelia aims to intervene before syrinx formation through early detection and management of the underlying disease.

Early detection and preemptive monitoring of Chiari I malformation: MRI is performed immediately in patients with symptoms such as cough-induced headache, neck pain and abnormal upper limb sensation. In patients with confirmed Chiari I malformation, the presence of syringomyelia is followed regularly (initially at 1-year intervals) by MRI. Surgical decompression performed before a syrinx forms or symptoms progress can prevent syrinx formation itself or suppress it early.

Follow-up after spinal cord injury: In patients with traumatic spinal cord injury, periodic spinal cord MRI follow-up is performed from 1–5 years after injury to detect post-traumatic syringomyelia early. MRI is performed immediately if symptoms of neurological decline above the level of spinal cord injury (ascending paralysis) appear.

Early detection of spinal cord tumor: In patients with neck or chest pain and neurological abnormalities, contrast-enhanced spinal cord MRI is performed to identify intratumoral syringomyelia early and plan surgical resection.

Screening in scoliosis of unknown cause: In children and adolescents with scoliosis accompanied by neurological abnormalities or showing an atypical pattern, spinal cord MRI is performed to exclude syringomyelia. If syringomyelia is found, treatment of the syringomyelia takes priority and the scoliosis is evaluated afterward.

Secondary prevention (preventing worsening): Patients diagnosed with syringomyelia are educated to refrain from Valsalva-provoking activities (lifting heavy objects, severe coughing, etc.). They are advised to avoid high-risk activities involving repeated spinal flexion and extension (skydiving, bungee jumping, combat sports, etc.). Use of cervical protective gear is recommended in sports activities with a risk of spinal cord injury.

13. References

  1. Oldfield EH, Muraszko K, Shawker TH, Patronas NJ. Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. J Neurosurg. 1994;80(1):3–15. PMID: 8271018
  2. Milhorat TH, Chou MW, Trinidad EM, et al. Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery. 1999;44(5):1005–1017. PMID: 10232534
  3. Heiss JD, Patronas N, DeVroom HL, et al. Elucidating the pathophysiology of syringomyelia. J Neurosurg. 1999;91(4):553–562. PMID: 10507374
  4. Attal N, Parker F, Tran P, et al. Effects of surgery on the sensory deficits of syringomyelia and predictors of outcome. J Neurol. 2004;251(9):1071–1077. PMID: 15372245
  5. Schijman E, Steinbok P. International survey on the management of Chiari I malformation and syringomyelia. Childs Nerv Syst. 2004;20(5):341–348. PMID: 14991358
  6. Alzate JC, Kothbauer KF, Jallo GI, Epstein FJ. Treatment of Chiari I malformation in patients with and without syringomyelia: a consecutive series of 66 cases. Neurosurg Focus. 2001;11(1):E3. PMID: 16466241
  7. Stoodley MA. Syringomyelia in animals, humans, and model systems. Prog Brain Res. 2000;125:3–14. PMID: 11098646
  8. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821–1828. PMID: 17978290
  9. Todor DR, Harrison MJ, Hemmer S, Dold O. Prevalence of syringomyelia in patients with intracranial disease. Acta Neurochir Suppl. 2000;76:29–33. PMID: 11450003
  10. Bonfield CM, Levi AD, Arnold PM, Okonkwo DO. Surgical management of post-traumatic syringomyelia. Spine (Phila Pa 1976). 2010;35(21 Suppl):S245–S258. PMID: 20881477